beta-2 adrenergic inverse agonists (Invion)

N/A

Report date: 2025/03/14 20:00:48

NME

Base Information

Drug Namebeta-2 adrenergic inverse agonists (Invion)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionBeta-2 adrenergic receptor agonists

TargetsBeta-2 adrenergic receptor

Therapy Area/IndicationsLung Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia and New Zealand

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesInvion Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesInvion Inc

Active IndicationsN/A

Inactive IndicationsLung Diseases

ATC CodeN/A